Meredith W. Cook - 18 Jul 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Reporting relationship: SR. VP, GENERAL COUNSEL & SEC.
Issuer ticker: ANIP
Reported as of: 18 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Jul 2026, 16:32:05 UTC
Prior SEC filing: 14 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Meredith W. Cook

Key filing fact

Meredith W. Cook filed Form 4 for ANI PHARMACEUTICALS INC (ANIP) on 21 Jul 2026.

Key facts

This page summarizes Meredith W. Cook's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Jul 2026, 16:32.

Change

Previous filing in this sequence was filed on 14 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001938861 Primary reporting owner

Cook Meredith

Relationship: SR. VP, GENERAL COUNSEL & SEC.
Address: C/O ANI PHARMACEUTICALS, INC., 104 CARNEGIE CENTER, SUITE 300, PRINCETON
Signature: /s/ Meredith W. Cook
Signature date: 21 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIP transaction

Common Stock

Tax liability

Transaction value
Shares: -2,466
Change %: -3.2%
Price: $79.20^*
Shares after: 74,924
Date: 18 Jul 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported on July 20, 2022.